Deutsche Bank AG Purchases New Holdings in The Cooper Companies, Inc. $COO

Deutsche Bank AG acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 853,483 shares of the medical device company’s stock, valued at approximately $61,203,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of COO. New York Life Investment Management LLC boosted its stake in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the last quarter. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the last quarter. Essential Partners LLC raised its holdings in Cooper Companies by 23.4% in the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after acquiring an additional 166 shares in the last quarter. Allworth Financial LP raised its holdings in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its stake in Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Cooper Companies stock opened at $76.16 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a fifty day moving average price of $71.76 and a two-hundred day moving average price of $71.12. The company has a market cap of $14.85 billion, a PE ratio of 64.54, a P/E/G ratio of 2.01 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the prior year, the company earned $0.96 earnings per share. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: The company’s latest reported quarter showed solid operating performance: adjusted earnings of $1.21 per share exceeded consensus by $0.11, revenue reached $1.08 billion versus expectations of $1.05 billion, and sales increased 7.9% year over year. COO also maintained fiscal 2026 EPS guidance of $4.58–$4.66.
• Neutral Sentiment: Recent headlines mentioning “Cooper,” “COO,” or cooperation—including Bass Oil’s Cooper Basin update, Wendy’s discussion of a chief operating officer role, and Trainline’s regulatory cooperation—do not concern The Cooper Companies and are not relevant catalysts for COO.
• Negative Sentiment: With no fresh corporate catalyst in the provided articles, the modest weakness may reflect normal trading, profit-taking, or valuation concerns. The stock trades at a relatively high price-to-earnings multiple of about 64.5, leaving shares sensitive to changes in investor expectations even after the recent earnings beat.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on COO shares. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. BNP Paribas Exane reduced their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Finally, Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.